Endocrine disorders have become more and more frequently diagnosed in humans and animals. In horses, equine metabolic syndrome (EMS) is characterized by insulin resistance, hyperleptinemia, hyperinsulinemia, inflammation and usually by pathological obesity. Due to an increased inflammatory response in the adipose tissue, cytophysiological properties of adipose derived stem cells (ASC) have been impaired, which strongly limits their therapeutic potential. Excessive accumulation of reactive oxygen species, mitochondria deterioration and accelerated ageing of those cells affect their multipotency and restrict the effectiveness of the differentiation process.
abundant infiltration of adipose tissue by pro-inflammatory (M1) macrophages and CD4 + T lymphocytes, combined with adipocytes' hypertrophy, induces its dysfunction, characterized by increased IR, hypoxia and enhanced apoptosis. [6] [7] [8] Furthermore, excessive accumulation of reactive oxygen species (ROS), nitric oxide (NO), protein kinase C activity, with a simultaneous decrease in superoxide dismutase (SOD) activity, which provides antioxidant defence, ultimately leads to the development of cardiovascular diseases in humans and can cause laminitis in horses. [9] [10] [11] Additionally, a growing body of evidence suggests that in addition to inflammation, excessive oxidative stress (OS), ie ROS generated by mitochondria (MTs), plays a critical role in the development of obesity-related diseases as well as degradation processes. 6, 12 Moreover, ectopic accumulation of lipids promotes lipotoxicity, which in turn impairs cellular functions not only of adipocytes, but also of other adipose tissue components, causing IR, apoptosis and inflammation. Microenvironment, combined with OS and inflammation in adipose tissues of EMS horses, is recognized as one of the most important factors that contributes to accelerated senescence and ageing. 1 Both inflammation and progressive ageing of adipose tissue are not without significance for adipose derived stem cells (ASCs) that reside within this tissue.
Adipose-derived mesenchymal stromal stem cells are increasingly often recognized as a therapeutic source of stem cells and recently have been extensively used in veterinary practice. 13 Clinical trials in humans have already been established for the intravenous administration of ASCs in autoimmune and inflammatory disorders, such as multiple sclerosis and arthritis. 14 The pro-regenerative properties of ASCs are explained by their paracrine and autocrine activities based on the secretion of membranederived extracellular vesicles (ExMVs), which are known to play a critical role in intracellular signalling. 15, 16 ExMVs were demonstrated to contain a broad range of growth factors, including vascular endothelial growth factors, fibroblast growth factors and transforming growth factor-b-all of which are crucial in the treatment of MetS. 17 Moreover, mesenchymal stem cells (MSCs) were shown to improve metabolic control in experimental models of type 2 diabetes (T2D), as measured by enhanced insulin secretion, improved insulin sensitivity and increased number of islet cells in the pancreas. 18 Therefore, they are a promising tool also in the field of endocrinology. RES is a well-known natural, polyphenolic compound and autophagy activator. What is more, RES has been thoroughly documented as an immunomodulatory, anti-inflammatory and antioxidant agent. 19, 21, 22 It has been shown that RES has the ability to prolong lifespan, increase insulin sensitivity and protect against age-related disorders, including T2D in mice fed a high-fat diet. 23 Moreover, it was found that RES activated AMPK/PGC-1a signalling, improved mitochondrial biogenesis and dynamics, reduced IGF-1 levels and inhibited apoptosis by stimulating autophagy in a mouse model of diabetic nephropathy. 22 Finally, a study conducted by Shakibaei et al showed that RES promoted osteogenic differentiation in human and mouse MSCs through Sirt1/Runx2 activation. Interesting data regarding the involvement of RES in mediating MT removal have been published recently. 23 It was shown that RES induced Pink and Parkin expression in senescent cardiomyocytes to degrade impaired MT. It has been speculated that the activation of these proteins may be a potential mechanism by which RES reverses the impairment of aged cells. ASC senescence and ageing, which is associated with DNA methylation, can be diminished by the application of DNA methyltransferase (DNMT) inhibitors, such as 5-azacitidine (5-AZA), which inhibits the methylation pattern of specific gene regions, while activating associated genes. 5-AZA is chemically an analogue of cytidine, commonly used in the treatment of acute myelogenous leukaemia. 24 However, it was shown in human-aged ASCs that 5-AZA reversed their aged phenotype, increased proliferative activity and improved osteogenic differentiation potential, while it decreased the accumulation of OS factors and DNA methylation status. 25 Moreover, a study conducted by Seeliger et al 26 
| MATERIALS AND METHODS
All reagents used in this experiment were purchased from SigmaAldrich (Poland), unless indicated otherwise.
| Qualification of horses
Animals were age-matched (mixed sex, 9-14 years; mean AE SD, 11.2 AE 1.7 years) and assigned into 2 groups: EMS (n = 5, 2 female, 3 male) and healthy horses (n = 5, 2 female, 3 male). Detailed characterization of animals used in this experiment is shown in 
| Cell culture
During the experiment, cells were cultured under aseptic and constant conditions in an incubator (37°C, 5% CO 2 and 95% humidity).
Culture medium consisted of DMEM with 4500 mg/L glucose supplemented with 10% fetal bovine serum (FBS) and 1% of penicillinstreptomycin (PS). Culture medium was changed every 3 days. Cells were passaged after reaching 90% confluence using trypsin solution (TrypLE TM Express; Life Technologies). 
| Immunophenotyping and multipotency assay

| Proliferation rate
Growth kinetics of ASCs was examined using a resazurin assay kit (TOX8), following the manufacturer's instructions. To perform the assay, cells were plated in 24-well plates at an initial concentration of 2 9 10 4 per well. Culture media were replaced with media containing 10% of resazurin dye and cells were incubated in a CO 2 incubator, 37°C for 2 hours. Next, supernatants were transferred to 96-well plates and subjected to spectrophotometric assay (Epoch; BioTek). The absorbance of the supernatants was measured at a wavelength of 600 nm for resazurin, and 690 nm reference wavelength. 
| SEM, TEM and FIB-SEM analysis
Detailed morphology of cells was evaluated using scanning electron microscope (Zeiss EVO LS15). First, cells were fixed in 4% PFA and washed with HBSS 3 times. Next, specimens were dehydrated in a graded ethanol series (from 50% to 100%). Air-dried samples were sputtered with gold (ScanCoat 6; Oxford), placed in a microscope chamber and observed using a SE1 detector, at 10 kV of filament's tension. SEM was equipped with a BRUCKER energy dispersive Xray system (SEM/EDX), which allowed to analyse the distribution of Ultrathin sections (80 nm) were collected on copper grids. Uranyl acetate and lead citrate were used for contrasting. The observations were carried out using Auriga60 Zeiss STEM, at 20 kV filament tension.
Cells were analysed using FIB-SEM using a previously described method. 27 Briefly, samples were fixed with 2.5% glutaraldehyde in 
| Confocal imaging
Prior MT visualization, cells were incubated with MitoRed dye Based on representative photographs, mitochondrial net was visualized in microP software. 30 
| Quantification of ALP levels
In order to examine extracellular ALP activity, an Alkaline Phosphatase Colorimetric Assay Kit (Abcam) was used in accordance with the manufacturer's protocol. In the assay, the p-nitrophenyl phosphate was used as a phosphatase substrate. Obtained product was measured at 405 nm wavelength (Epoch; BioTek). The amount of pNP was obtained by sample readings applied to a standard curve.
ALP activity was calculated using the following formula: ALP activity (U/mL) = A/V/T (where A-pNP amount; V-volume of sample added to well (mL); T-reaction time).
| Oxidative stress factors and senescence
Nitric oxide concentration was assessed using reagent kit (Life Technologies) while SOD activity was measured using a SOD Assay kit 
| siRNA transfection
To knock down PARKIN expression in ASC EMS , a PARKIN small interfering RNA (siRNA) construct was purchased and tested for knockdown efficiency. ASC were seeded at an initial density of Technologies) . After 72 hours, total RNA was isolated from cells using TRI Reagent.
| Reverse-transcription polymerase chain reaction (RT-PCR)
In order to isolate total RNA, cells were homogenized with 1 mL of TRI Reagent. Total RNA was isolated according to method described by Chomczynski and Sacchi. 31 The quantity and quality of received genetic material were estimated using a nanospectrophotometer (Epoch; Biotek). Genomic DNA was digested using DNase I, RNAasefree (Life Technologies) while complementary DNA (cDNA) synthesis was performed using RevertAid RT Reverse Transcription Kit (Life Technologies). Each reaction contained 150 ng of total RNA. Both procedures were carried out following the manufacturer's protocol using T100 Thermal Cycler (Bio-Rad) as described elsewhere. Table 2 .
To determine miRNA expression, 500 ng of RNA was reverse- 
| Co-culture of ASC with RAW 264.7
RAW 264.7 were counted, adjusted to a density of 1 9 10 6 cells/ mL and seeded onto a 24-well plate in a volume of 500 lL/well.
After 18 hours, non-adherent cells were removed by a gentle wash with warm HBSS. Next, LPS was added to the culture media at a concentration of 1 lg/mL and the experiment was continued for another 24 hours. At the same time, ASC in the amount of 4 9 10 4 was added to culture wells. After 24 hours of co-culture, media were collected for analysis of the macrophages' secretory activity, and the cells were lysed by adding TRI Reagent.
| ELISA assays
The concentration of TNF-a and OPN protein in cell-free culture supernatants was determined by solid-phase ELISA using the Mouse 
| Western blotting
Cells were detached from culture dishes and homogenized in RIPA buffer plus protease inhibitor cocktail. The lysates were centrifuged at 4°C for 20 minutes (14 000 g) and supernatants were transferred to new tubes. Thirty micrograms of protein were used for each sample. SDS-PAGE was performed at 100 V for 90 minutes in Tris/ glycine/SDS buffer. Proteins were transferred onto a polyvinylidene difluoride membrane (Bio-Rad) using a transfer apparatus at 100 V for 1 hour at 4°C in Tris/glycine buffer. After transfer, the membrane was washed with Tris/NaCl/Tween buffer (TBST) and blocked overnight at 4°C with 5% non-fat milk in TBST. Next, the membrane was washed with TBST and incubated with primary antibody for 
| Statistical analysis
All experiments were performed at least in 3 replicates. Differences between experimental groups were estimated using unpaired student's t test. Statistical analysis was conducted with GraphPad Prism 5 Software (La Jolla, USA). Differences with probability of P < .05
were considered significant. Statistical significance is indicated as asterisk (*) when comparing the result to ASC CTRL , and as hashtag (#) when comparing to ASC EMS .
| RESULTS
| Immunophenotyping and multipotency assay
In order to characterize surface marker expression, cells were anal- and comparable to control, healthy cells ( Figure 2B , P < .001). Proliferation rate during osteogenesis was assessed during 3 distinct time points. D0 refers to day after cell seeding, d1 after 24 hours of AZA/ RES treatment and D5 to fifth day of osteogenic differentiation. Statistically significant differences in the proliferation rate during differentiation were only noted at day D1, as both ASC EMS and ASC EMS AZA/RES displayed increased proliferation in comparison to the control group ( Figure 2C , P < .01). PDT in ASC EMS was down-regulated in comparison to control cells ( Figure 2D , P < .01) and ASC EMS AZA/RES (P < .05). Furthermore, during osteogenic differentiation, incorporation of BrdU was investigated in counterpart time points.
No differences were noted between ASC EMS and ASC EMS AZA/RES .
However, incorporation of BrdU in ASC EMS at D1 decreased in comparison to ASC CTRL while increased at D3 and D5 ( Figure 2E , P < .01
and P < .05, respectively).
| Evaluation of osteogenesis effectiveness
Photographs taken with light microscope indicated the robust formation of mineralized matrix in ASC CTRL . On the contrary, ASC EMS were characterized by an increased number of undifferentiated cells. However, treatment with AZA/RES markedly enhanced the differentiation process ( Figure 3A) . Using RT-PCR we evaluated the expression of osteogenic-related genes. RUNX 2 mRNA was down-regulated in ASC EMS in comparison to the control group ( Figure 3B , P < .01); however, AZA/RES treatment significantly enhanced its expression (P < .001). Collagen I expression was diminished in ASC EMS ( Figure 3C , P < .001), although after AZA/RES treatment its levels increased (P < .05). No statistically significant differences were found in the expression of BMP-2 between groups. ASC EMS preconditioned with AZA/RES significantly enhanced the secretion of OPN ( Figure 3E , P < .01). However, both ASC EMS and ASC EMS AZA/RES displayed diminished ALP activity in comparison to control cells ( Figure 3F , P < .01
and P < .001 respectively). IL-10 secretion by MSC is associated with the promotion of osteoblastic differentiation. We found decreased synthesis of IL-10 in ASC EMS ( Figure 3G , P < .001); however, its production was significantly increased in AZA/RES group (P < .001). Furthermore, the expression of miR-451 was significantly up-regulated after AZA/RES treatment ( Figure 3H , P < .001).
| Assessment of bone mineralization
Using SEM with EDX and CzBSD detectors, we evaluated the effectiveness of mineralized matrix formation ( Figure 4A ). CzBSD detector allowed for the visualization of organic compounds (brighter signal refers to more organic compounds), whereas EDX was used for the evaluation of Ca and P content. Results obtained as photographs were further quantified. The number of bone nodules was decreased in ASC EMS in comparison to the control group ( Figure 4B , P < .001);
however, AZA/RES treatment significantly increased nodules' number (P < .05). Analogous phenomenon was observed in nodules' size ( Figure 4C ). Ca and P amounts were significantly down-regulated in ASC EMS ( Figure 4D , P < .001 and P < .01, respectively). However, Ca levels were increased in ASC EMS AZA/RES (P < .01). Notably, AZA/ RES treatment did not affect P concentration. Furthermore, the ratio of Ca and P was calculated ( Figure 4E ). Robust accumulation of Ca in comparison to P was observed in ASC EMS (P < .01), while AZA/ RES treatment resulted in a decreased ratio of Ca and P (P < .01).
| Accumulation of oxidative stress factors
In order to evaluate mitochondrial membrane potential (MMP) with a flow cytometer, cells were subjected to analysis after day 1 of differentiation to avoid machine breakdown. Representative plots are shown in Figure 5A . MMP was significantly down-regulated in ASC EMS ( Figure 5B , P < .01), although AZA/RES treatment resulted in increased MMP (P < .001). Antioxidative capacity of cells was estimated by the evaluation of SOD activity. No differences were noted between control and EMS groups, whereas F I G U R E 1 Immunophenotyping and multipotency assay. In order to confirm the multipotent character of isolated cells, they were analysed for CD44, CD45 and CD90 surface antigens' expression with flow cytometer (A). Furthermore, cells were differentiated into chondrogenic, osteogenic and adipogenic lineage (B). Effectiveness of differentiation was confirmed by specific staining ASC EMS AZA/RES was characterized by an enhanced SOD activity ( Figure 5C , P < .01). Accumulation of NO was increased in ASC EMS ( Figure 5D , P < .01), although AZA/RES treatment diminished its levels (P < .01). Analogous phenomenon was observed in the measurement of ROS levels as shown in Figure 5E .
| Senescence and apoptosis
For visualization of senescence in cultures, staining for b-galactosi- We further examined the expression of apoptotic-related genes during osteogenesis. We found increased mRNA levels of p53 in ASC EMS in comparison to ASC CTRL ( Figure 6B ). No differences were noted between ASC EMS and ASC EMS AZA/RES. Expression of p21 was up-regulated in ASC from EMS horses ( Figure 6C , P < .01); however, AZA/RES treatment reduced its levels in comparison to untreated cells (P < .05). Similar phenomenon was noted in the case of caspase-3 ( Figure 6D ) and caspase-9 ( Figure 6E) expression.
F I G U R E 2
Proliferation of cells pretreated with AZA/RES in control and osteogenic conditions. Cells were cultured in standard medium supplemented with AZA/RES for 24 h and subjected to alamar blue assay in order to investigate their proliferation rate (A). Untreated cells served as a control group (CTRL and EMS). Furthermore, PDT was assessed as well (B). Proliferation rate (C) PDT (D) and BrdU (E) established for cells cultured in osteogenic medium. Results expressed as mean AE SD. Statistical significance indicated as asterisk (*) when comparing the result to ASC CTRL , and as hashtag (#) when comparing to ASC EMS. #P < .05, ##P < .01, *P < .05, ***P < .001
| Evaluation of ER stress
As it was shown that ER stress is involved in the progression of osteogenesis, we decided to investigate ER ultrastructure and expression of genes related to ER stress pathway. TEM images indi- F I G U R E 3 Evaluation of osteogenesis effectiveness. After day 5 of osteogenesis, cells were captured using inverted, light microscope (A) and the formation of a mineralized matrix was visualized. Using RT-PCR we analysed the expression of osteogenic-related genes including RUNX 2 (B), collagen I (C) and BMP-2 (D). Secretion of OPN was tested with ELISA assay (E). ALP activity (F) was reduced in both EMS groups as indicated (F). As IL-10 plays a role in osteogenic differentiation, we evaluated its amount with ELISA (G). Furthermore, using RTR-PCR the expression of miR-451 was tested (H). Results expressed as mean AE SD. Statistical significance indicated as asterisk (*) when comparing the result to ASC EMS , and as hashtag (#) when comparing to ASC CTRL. ##P < .01, ###P < .001, *P < .05, **P < .01, ***P < .001. Matrix mineralization in cells cultured in control and AZA/RES conditions. Using SEM we visualized the detailed morphology of newly formed matrix, levels of organic material within bone nodules (CzBSD), Ca and P concentration (A). Data obtained from SEM were further quantified as mean number of bone nodules (B), their size (C), amount of Ca/P (D) as well as Ca/P ratio were calculated (E). Results expressed as mean AE SD. Statistical significance indicated as asterisk (*) when comparing the result to ASC EMS , and as hashtag (#) when comparing to ASC CTRL . ##P < .01, ###P < .001, *P < .05, **P < .01, ***P < .001
| Evaluation of autophagy
As autophagy plays an important role in cell survival and differentiation, we decided to investigate its levels during osteogenesis. For that reason, immunofluorescence for LAMP-2 was performed (Figure 8A) . The obtained results indicated that there was an increase in LAMP-2 amount in ASC EMS and in ASC EMS AZA/RES. Moreover, cells were also counterstained with MitoRed for MT visualization.
The obtained results revealed increased MT activity in the control group which supports the data received with JC-1 assay. SQSTM expression was increased in ASC EMS ( Figure 8B , P < .01) and AZA/ RES treatment augmented its expression even more (P < .01). Similarly, the expression of Beclin 3 ( Figure 8C ) was also up-regulated in those groups (P < .01 and P < .05, respectively). Interestingly, no differences were noted in the expression of LC3 ( Figure 8D ).
LAMP-2 expression was up-regulated in ASC EMS in comparison to
ASC CTRL ; however, no differences were found between ASC EMS and ASC EMS AZA/RES. For that reason, we performed western blot for LAMP-2 as well. Signal intensity was the greatest in ASC EMS AZA/RES ( Figure 8F ) .
| Assessment of mitochondrial dynamics
Mitochondrial morphology was evaluated using TEM microscope Western blot for MFN indicated its increased synthesis in ASC CTRL ( Figure 9E) . Furthermore, the shape of mitochondrial net was visualized by MitoRed ( Figure 9F ). Obtained photographs were subjected to microP software analysis ( Figure 9G ). In accordance with the data generated by the software, ASC EMS and ASC EMS AZA/RES were characterized by decreased MT number per cell (Figure 9H) . Moreover, the number of globular MT was diminished in ASC EMS in comparison to ASC CTRL ( Figure 9I , P < .05). Treatment of ASC EMS with AZA/RES decreased globular organelles' number (P < .05). An opposite trend was observed in the amount of tubular MT ( Figure 9J ). Their number was increased in ASC EMS in comparison to ASC CTRL (P < .05). However, ASC EMS preconditioned with AZA/RES were characterized by increased tubular organelles in comparison to untreated cells (P < .05).
| Evaluation of mitophagy
Mitophagy was assessed using FIB-TEM. Increased formation of mitophagosomes was noted in ASC EMS and ASC EMS AZA/RES (Figure 10A) . To support the qualitative results from the images, we per- as indicated in Figure 11C . Furthermore, TNF-a secretion was analysed with ELISA assay ( Figure 11D ). Increased amount of TNF-a was noted in ASC EMS in comparison to the control group. However, AZA/ RES treatment significantly down-regulated the TNF-a level (P < .001). Using spectrophotometric assay, the amount of NO was investigated; however, no statistically significant differences were noted in the investigated groups ( Figure 11E ).
| Epigenetic changes during differentiation
In order to investigate epigenetic alternations in cells, we analysed with flow cytometer 5-mC and histone H3 accumulation. No ( Figure 11F ) and TET-3 ( Figure 11G ) as AZA/RES treatment significantly decreased their mRNA amount (P < .001).
| DISCUSSION
The present study has demonstrated that ex vivo treatment of ASC EMS with a combination of AZA/RES improved osteogenic differentiation of these cells in comparison to non-treated cells. by controlling cytokine signalling and matrix remodelling, which was consistent with our results. Moreover, it was shown that DNAdemethylation was associated with the induction of the TET gene expression, which initiated the conversion of nuclear 5-methylcytosine (5 mC) to 5-hydroxymethylcytosine (5 hmC). In our previous work, we showed that 5-AZA reversed the aged phenotype of human ASCs isolated from elderly patient by increasing the proliferation, viability and metabolic activity through a higher BCL-2/BAX ratio combined with reduced expression of p21/p53/Cas-9. 25 However, the expression of TET2 and TET3 was comparable between the control and AZA/RES groups in our study. Recent studies suggested that the expression of TET 2 and TET3 might be impaired under pathological conditions, ie haematological malignancies, melanoma and/or neurodegeneration. 46 ,47 However, it should be taken into account that our data concerns the fifth day of osteogenesis, and TET proteins may be switched on earlier in the AZA/RES group because epigenetic alternations are necessary for the differentiation process.
Oxidative stress is recognized as a major factor contributing to the deterioration of ASC multipotency, isolated from patients with several conditions, including obesity, diabetes and ageing. 20, 21 Our previous research has shown that autophagy in ASC EMS serves as a protective mechanism that allows to maintain cellular homeostasis and stemness. We have confirmed increased mitophagy in ASC EMS treated with AZA/RES using RT-PCR, TEM-FIB and confocal microscopy. In this study, we observed the overexpression of SQSTM1 as previously shown by our group. 27, 28 The research conducted by Kornicka et al 34 showed that RES incorporated into polyurethanepolylactide-based material induced PINK/PARKIN expression in F I G U R E 1 2 Evaluation of epigenetic alternations after AZA/RES treatment. Representative graphs are showing flow cytometry results (A). 5-mC (B)-positive cell number was significantly decreased after AZA/RES treatment. On the other hand, AZA/RES augmented the number of histone H3-positive cells (C). TET-2 protein levels were visualized using western blot (D). Moreover, the expression of DNMT-1 (E), TET-2 (F) and TET-3 (G) was tested by RT-PCR analysis. Results expressed as mean AE SD. Statistical significance indicated as asterisk (*) when comparing the result to ASC EMS , and as hashtag (#) when comparing to ASC CTRL . #P < .05, ###P < .001, *P < .05, ***P < .001
humans ASCs, which was associated with increased expression of osteogenic markers. We observed in the current study that the 
